Date for the diary - Workshop on Sponsorship and Governance of Clinical Research


Molecular Medicine Ireland is organising a half day workshop to address the issue of sponsorship of clinical research and to identify solutions on Thursday 16 September in Dublin – venue to be announced.
The workshop will explore why an effective and coherent framework for research governance and sponsorship is the necessary foundation to guarantee that Irish research activities will be performed to best national and international research practice. It will examine how this framework assures funders and agencies that PIs performing research are doing so in an environment which assures the correct level of research oversight, research compliance and adherence to the appropriate legislative and regulatory requirements.
The workshop will sketch the current landscape of research governance and sponsorship nationally and internationally. Furthermore, it will identify what needs to be done to optimise and facilitate PIs to perform research in a supportive environment in all types of research involving human participants, such as, medicinal products, surgical and radiotherapy research, biomarker and diagnostic research, medical devices, stem cell and other advanced therapies and neutraceuticals.
The outputs will focus on issues and propose solutions to enable:
•Single centre research
•Multi-centre research in Ireland only
•Multi-centre and multi-national research – where an Irish Institution is acting as research lead/sponsor or as participant in externally sponsored project
The workshop will look at the current developments in addressing the needs of research governance and sponsorship using case studies which showcase the progress to date and the challenges remaining.
Speakers include Professor Stephen K. Smith, Principal of the Faculty of Medicine and Chief Executive of Imperial College Healthcare NHS Trust, Professor William Powderly, Chief Academic Officer, Dublin Academic Health Care and Head of School, UCD School of Medicine and a representative of the Irish Medicines Board.
The target audience are PIs, Clinical Scientists, Hospital and University based clinical researchers and research directors and managers, CEOs and Hospital managers, ethics committee representatives, sponsors of research in medicinal products, medical devices and diagnostics and agencies that interface with the variety or research activities being conducted by the Irish research community, research funders and economic development agencies.
To register an interest in attending this workshop please email : info@molecularmedicineireland.ie